Applied DNA Secures 1-Year Contract Extension with DLA for DNA-marking with SigNature® DNA

Extends Uninterrupted Support for FSC 5962 Microcircuits STONY BROOK, N.Y. (November 20, 2017) – Applied DNA Sciences, Inc. (NASDAQ: APDN; “Applied DNA”) today announced that the Defense Logistics Agency (DLA) has awarded the Company a one-year extension of its current contract through October 13, 2018. This agreement maintains consistent support of the DNA marking [...]

Applied DNA Awarded U.S. Patents on SigNature® T Molecular Tag and Multimode Reader Authentication Device

New patents protect SigNature T molecular tagging technology and a multimode reader device enabling IT integrated instant authentication  STONY BROOK, N.Y. (November 3, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN) is pleased to announce the issuance of U.S. Patent No. 9,790,538 (US 2014/0256881) entitled “Alkaline Activation for Immobilization of [...]

Palmetto Synthetics Signs CertainT Trademark License Agreement with Applied DNA for Synthetic Fiber Manufacture to Ensure Supply Chain Traceability, Transparency and Trust

CertainT Tag-Test-Track System at the Synthetic Yarn Fiber Association on October 27, 2017 in Charlotte, North Carolina  STONY BROOK, N.Y. (October 24, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), has signed a new CertainT® trademark license agreement with Palmetto Synthetics (“Palmetto”), a leader in the production of high quality, [...]

Techmer PM signs CertainT Trademark License Agreement with Applied DNA for PET Masterbatch Designating Product Integrity and Supply Chain Transparency

Tag-Test-Track Masterbatch Systems to be Unveiled at the Synthetic Yarn Fiber Association on October 27, 2017 STONY BROOK, N.Y. (October 23, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), has signed a new CertainT® trademark license agreement with Techmer PM (“Techmer”), a respected producer of value added colors and additives [...]

Applied DNA’s SigNature® Molecular Tag Technology Inducted into Material ConneXion’s Innovation Library

Product designers from around the world have access to and learn about SigNature T to embed into their products STONY BROOK N.Y. October 19, 2017 – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN) today announced that its SigNature molecular tag technology has been inducted into Material ConneXion’s prestigious library of innovative [...]

APDN, Videojet Enter Strategic Partnership to Offer New Security Print Platform to Diverse Commercial Ecosystems

STONY BROOK, N.Y. September 26, 2017 - Applied DNA Sciences, Inc. ("Applied DNA," "the company," NASDAQ: APDN), has entered into a strategic partnership with VideojetTechnologies (Videojet). Applied DNA and Videojet have collaborated in the design of co-branded Applied DNA SigNature® molecular-tagged Videojet inks, and a co-branded printer that electronically restricts the use of ink cartridges to only [...]

APDN to Present at 2017 Disruptive Growth Company Showcase

STONY BROOK, N.Y. September 21, 2017 – Applied DNA Sciences, Inc. (NASDAQ: APDN), announced that Dr. James Hayward, president & CEO, will present at the 2017 Disruptive Growth Company Showcase at the Grand Hyatt in New York City on Wednesday, September 27 at 2:30 p.m. ET. Dr. Hayward will present to an audience of investors [...]

APDN Files Form S-3 Registration Statement

STONY BROOK N.Y. (September 18, 2017) – Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,” NASDAQ: APDN), today announced that it has filed a Registration Statement with the Securities and Exchange Commission (the “Registration Statement”) with respect to the sale by certain selling security holders of common stock to be received upon exercise of warrants [...]

APDN Signs CRADA with U.S. Army to Study Commercialization of Rapid In-Field DNA Detection Technology

STONY BROOK, N.Y. September 12, 2017 - Applied DNA Sciences, Inc. (“Applied DNA”, “the Company”, NASDAQ: APDN), is proud to announce the signing of a Cooperative Research and Development Agreement (“CRADA”) with the U.S. Army Research, Development and Engineering Command’s Edgewood Chemical Biological Center (“ECBC”) to study the commercialization of ECBC’s innovative rapid, [...]

Applied DNA Reports Fiscal Third Quarter 2017 Financial Results

STONY BROOK, N.Y., August 10, 2017 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”, or "the Company"), announced financial results for the fiscal 2017 third quarter ended June 30, 2017. "We continued to make excellent progress in driving market adoption of our DNA technology platform in the fiscal third quarter while [...]